Goals of treatment in age-related macular degeneration
The primary goal of treatment is to maintain visual function and limit further damage to the macula. Because changes to the retina cannot be fully reversed, management focuses on preserving remaining vision.
Treatment is tailored to the individual and adjusted over time based on response and progression.
Individualised treatment approach
Age-related macular degeneration varies in how it develops and progresses. Treatment decisions are based on the form of the condition, the degree of visual change and findings on retinal examination.
Regular reassessment ensures that management remains appropriate.
Treatment approaches in age-related macular degeneration
Monitoring and observation
In early or less active forms, active treatment may not be immediately required. Regular monitoring allows changes to be detected early and guides when intervention may be needed.
This approach is often used when vision remains stable.
Intravitreal injections
In more active forms of age-related macular degeneration, treatment may involve injections into the eye. These medications are used to reduce abnormal blood vessel activity and help stabilise the macula.
Injections are performed under controlled conditions and may be required at regular intervals depending on response.
Nutritional support
Certain formulations of nutritional supplements may be recommended in specific stages of age-related macular degeneration. These are used to support retinal health and may help reduce the risk of progression in some cases.
Cites the Age-Related Eye Disease Study (AREDS) as having shown that multi-vitamins containing antioxidants and eye vitamins and minerals can reduce the risk of progression of moderate to advanced AMD.Treatment based on type of age-related macular degeneration
Dry age-related macular degeneration
Management is typically focused on monitoring and supporting retinal health. Progression is usually gradual, and regular assessment is important to detect any changes.
Wet age-related macular degeneration
This form often requires active treatment. Intravitreal injections are commonly used to stabilise the condition and reduce further changes in central vision.
Early detection and timely treatment are important in preserving visual function.
Monitoring response to treatment
Ongoing assessment is used to evaluate how the retina responds to treatment. This may include imaging and visual function testing to track changes over time.
Treatment frequency and approach may be adjusted based on these findings.
Adapting treatment over time
Management may change depending on how the condition progresses. Some individuals may require more frequent treatment, while others remain stable with less intervention.
Long-term care is essential in maintaining visual function.
Importance of adherence and follow-up
Consistent follow-up and adherence to the recommended treatment plan are essential. Missing appointments or delaying treatment may increase the risk of progression.
Clear understanding of the treatment plan supports better outcomes.